Breaking News, Financial News

Financial Report: Akorn

Achieves record 4Q and FY revenue

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akorn 4Q Revenues: $71.5 million (+68%) 4Q Earnings: $8.8 million  (+54%) FY Revenues: $256.2 million (+87%) FY Earnings: $35.4 million (-18%) Comments: Growth in the quarter and FY was driven by the Lundbeck and Kilitch acquisitions, the sale of newly approved and re-launched products, and growth of established products, offset by decreases in the U.S. contract services business....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters